摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-Diazaspiro(2,5)octane, 1-methyl- | 61008-71-7

中文名称
——
中文别名
——
英文名称
1,2-Diazaspiro(2,5)octane, 1-methyl-
英文别名
7-methyl-7,8-diazabicyclo[4.2.0]octane
1,2-Diazaspiro(2,5)octane, 1-methyl-化学式
CAS
61008-71-7
化学式
C7H14N2
mdl
——
分子量
126.2
InChiKey
UMFQNONQAVOOGO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES
    申请人:INVICTUS ONCOLOGY PVT. LTD.
    公开号:US20160145284A1
    公开(公告)日:2016-05-26
    The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to platinum based compounds comprising platinum moiety, linker moiety and lipid moiety and corresponding nanoparticles thereof. The disclosure further relates to synthesis of said platinum based compounds, nanoparticles and compositions comprising said platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by employing aforesaid carbene compounds, platinum based compounds, nanoparticles and compositions thereof.
    本公开涉及纳米技术和癌症治疗领域。特别地,本公开涉及包含铂基团、链接基团和脂质基团的铂基化合物及其相应的纳米粒子。本公开还涉及所述铂基化合物、纳米粒子的合成和包含所述铂基化合物/纳米粒子的组合物。本公开还涉及使用上述卡宾化合物、铂基化合物、纳米粒子和其组合物治疗癌症的方法。
查看更多

同类化合物

1,2-Diisopropyl-1,2-diazetidin 1,2-Diazaspiro(2,5)octane, 1-methyl- 1,2-Dimethyl-1,2-diazetidin diethyl (E)-3-(chloromethylene)-1,2-diazetidine-1,2-dicarboxylate 2,3-bis(carbethoxy)-2,3-diazabicyclo<2.2.0>hex-5-ene 1,3-Dicyclohexyl-1,3-diazetidine 3-bromo-3,4,4-trimethyl-3,4-dihydrodiazete 1.2-dioxide 1,2-Diazete, 3,4-dihydro-3,3,4-trimethyl-, 1,2-dioxide 1-bromo-6-methyl-7,8-diazabicyclo[4.2.0]oct-7-ene-7,8-dioxide di-tert-butyl 3-methylene-1,2-diazetidine-1,2-dicarboxylate 4-Oxa-1,7-diazabicyclo[5.2.0]nonane 4-Bromo-3,3-dimethyl-1-oxo-1,2-diazetidin-1-ium-2-olate 1-Oxo-1,2-diazetidin-1-ium-2-olate diethyl (1RS,6SR)-7,8-diazabicyclo[4.2.0]octane-7,8-dicarboxylate diethyl 7,8-diazabicyclo[4.2.0]oct-1-ene-7,8-dicarboxylate (S)-diethyl 3-methyl-1,2-diazetidine-1,2-dicarboxylate diethyl 3-methylene-1,2-diazetidine-1,2-dicarboxylate (3R)-3,4,4-trimethyl-1-oxido-2-oxodiazetidin-2-ium-3-ol diamino (3R)-3-ethoxydiazetidine-1,2-dicarboxylate 3-ethoxy-[1,2]diazetidine-1,2-dicarboxylic acid dimethyl ester 1,2,2,3,4,4-Hexamethyl-1,3-diazetidine 1,3-Diazetidine;ethane 1,3-Diazabicyclo[1.1.0]butane [4-(Aminomethyl)-1,3-diazabicyclo[1.1.0]butan-2-yl]methanamine 2-(1,3-Diazetidin-2-yl)-1,3-diazetidine 9-Oxido-9-aza-8-azoniabicyclo[5.2.0]nonane 8-oxide (3S)-3,4,4-trimethyl-1-oxido-2-oxodiazetidin-2-ium-3-ol dimethyl (3S)-3-ethoxydiazetidine-1,2-dicarboxylate diamino (3S)-3-ethoxydiazetidine-1,2-dicarboxylate 2,4-Dithia-3,6,7-triazabicyclo[3.2.0]heptane 1,1-Dimethyldiazetidin-1-ium Diazaspiro[3.3]heptane 2-Methyl-1,2-diazaspiro[3.5]nonane 2-Thia-1,6-diazabicyclo[3.2.0]heptan-7-one 1,2-Diazabicyclo[1.1.0]butane 2-Aza-1-azoniabicyclo[1.1.0]butane 2,4-Dioxa-3,6,7-triazabicyclo[3.2.0]heptane 1-(Diazetidin-1-yl)diazetidine 2-(Diazetidin-1-yl)ethanol 1,2-Diazaspiro[3.4]octane;hydrochloride 1,2-Diazaspiro[3.4]octane 1,2-Diazaspiro[3.5]nonane-2-carboxylic acid 3,4,4-Trimethyl-1,2-dioxido-diazete-1,2-diium-3-ol 1,3-Diazetidine 1,2-Diazetidine 3-hydrazino-3,4-bis-trifluoromethyl-[1,2]diazetidine 3,4-Dihydro-3,3,4,4-tetramethyl-1,2-diazete 1,2-dioxide 1,3-dichloro-1,3-diazetidine-2,4-dione